ArticleEuropean journal of nuclear medicine and molecular imaging2026

Prompt PSA changes as a prognostic marker for response to PSMA-radioligand therapy.

Wolfram A Bosbach et al.PubMed ↗Publisher ↗

No numbers read from the abstract.